139 related articles for article (PubMed ID: 8184910)
21. Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation.
Imamura M; Luo B; Limbird J; Vitello A; Oka M; Ivy DD; McMurtry IF; Garat CV; Fallon MB; Carter EP
J Appl Physiol (1985); 2005 Feb; 98(2):739-47. PubMed ID: 15516365
[TBL] [Abstract][Full Text] [Related]
22. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
[TBL] [Abstract][Full Text] [Related]
23. Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats.
Garjani A; Wainwright CL; Zeitlin IJ; Wilson C; Slee SJ
J Cardiovasc Pharmacol; 1995 Apr; 25(4):634-42. PubMed ID: 7596133
[TBL] [Abstract][Full Text] [Related]
24. The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
Holm P; Liska J; Franco-Cereceda A
Cardiovasc Res; 1998 Mar; 37(3):765-71. PubMed ID: 9659461
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.
Yan LD; Kong LL; Yong Z; Dong HJ; Chi MG; Pan XF; Zhang C; Liang YJ; Gong ZH; Liu KL
J Cardiovasc Pharmacol; 2010 Sep; 56(3):246-54. PubMed ID: 20531217
[TBL] [Abstract][Full Text] [Related]
26. Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats.
Itoh H; Yokochi A; Yamauchi-Kohno R; Maruyama K
Eur J Pharmacol; 1999 Jul; 376(3):233-8. PubMed ID: 10448881
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of CI-1020, an endothelin-A receptor antagonist, in hypoxic pulmonary hypertension.
Haleen S; Schroeder R; Walker D; Quenby-Brown E; Welch K; Hallak H; Uprichard A; Keiser J
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S331-5. PubMed ID: 9595473
[TBL] [Abstract][Full Text] [Related]
28. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic characterization of an endothelinA (ETA) receptor antagonist in conscious rats.
Bazil MK; Lappe RW; Webb RL
J Cardiovasc Pharmacol; 1992 Dec; 20(6):940-8. PubMed ID: 1282597
[TBL] [Abstract][Full Text] [Related]
30. Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs.
Takeoka M; Ishizaki T; Sakai A; Chang SW; Shigemori K; Higashi T; Ueda G
Acta Physiol Scand; 1995 Sep; 155(1):53-60. PubMed ID: 8553877
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.
Gien J; Tseng N; Seedorf G; Kuhn K; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1090-L1100. PubMed ID: 27760762
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of pulmonary arterial smooth muscle cell proliferation following hypoxic pulmonary hypertension by the Na+/H+ exchange inhibitor amiloride.
Liu Y; Zhang B; Dong MQ; Niu W; Luo Y; Gao YQ; Li ZC
Chin J Physiol; 2010 Feb; 53(1):36-44. PubMed ID: 21789883
[TBL] [Abstract][Full Text] [Related]
33. Partial reversal of hypoxic pulmonary hypertension by heparin.
Hassoun PM; Thompson BT; Hales CA
Am Rev Respir Dis; 1992 Jan; 145(1):193-6. PubMed ID: 1731584
[TBL] [Abstract][Full Text] [Related]
34. Effects of electro-acupuncture on endothelium-derived endothelin-1 and endothelial nitric oxide synthase of rats with hypoxia-induced pulmonary hypertension.
Pan P; Zhang X; Qian H; Shi W; Wang J; Bo Y; Li W
Exp Biol Med (Maywood); 2010 May; 235(5):642-8. PubMed ID: 20463305
[TBL] [Abstract][Full Text] [Related]
35. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
36. Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats.
Soma S; Takahashi H; Muramatsu M; Oka M; Fukuchi Y
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):620-30. PubMed ID: 10100993
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary vascular adaptations to augmented polycythemia during chronic hypoxia.
Petit RD; Warburton RR; Ou LC; Hill NS
J Appl Physiol (1985); 1995 Jul; 79(1):229-35. PubMed ID: 7559224
[TBL] [Abstract][Full Text] [Related]
38. The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertension.
Sheedy W; Haleen S; Morice AH
Pulm Pharmacol Ther; 1998; 11(2-3):173-6. PubMed ID: 9918751
[TBL] [Abstract][Full Text] [Related]
39. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.
Ivy DD; Parker TA; Ziegler JW; Galan HL; Kinsella JP; Tuder RM; Abman SH
J Clin Invest; 1997 Mar; 99(6):1179-86. PubMed ID: 9077525
[TBL] [Abstract][Full Text] [Related]
40. Acute and chronic hypoxic pulmonary hypertension in guinea pigs.
Thompson BT; Hassoun PM; Kradin RL; Hales CA
J Appl Physiol (1985); 1989 Feb; 66(2):920-8. PubMed ID: 2708221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
